• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

快速选择与具有功能上不可能突变的中和抗体 B 细胞谱系成员结合的 HIV 包膜。

Rapid selection of HIV envelopes that bind to neutralizing antibody B cell lineage members with functional improbable mutations.

机构信息

Duke Human Vaccine Institute, Duke University, Durham, NC 27610, USA.

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20814, USA.

出版信息

Cell Rep. 2021 Aug 17;36(7):109561. doi: 10.1016/j.celrep.2021.109561.

DOI:10.1016/j.celrep.2021.109561
PMID:34407396
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8493474/
Abstract

Elicitation of broadly neutralizing antibodies (bnAbs) by an HIV vaccine will involve priming the immune system to activate antibody precursors, followed by boosting immunizations to select for antibodies with functional features required for neutralization breadth. The higher the number of acquired mutations necessary for function, the more convoluted are the antibody developmental pathways. HIV bnAbs acquire a large number of somatic mutations, but not all mutations are functionally important. In this study, we identify a minimal subset of mutations sufficient for the function of the naturally occurring V3-glycan bnAb DH270.6. Using antibody library screening, candidate envelope immunogens that interact with DH270.6-like antibodies containing this set of key mutations are identified and selected in vitro. Our results demonstrate that less complex B cell evolutionary pathways than those naturally observed exist for the induction of HIV bnAbs by vaccination, and they establish rational approaches to identify boosting candidate immunogens.

摘要

通过 HIV 疫苗诱导广泛中和抗体(bnAbs)将涉及启动免疫系统激活抗体前体,然后进行加强免疫,以选择具有中和广度所需功能特征的抗体。获得功能所需的突变数量越高,抗体的发育途径就越复杂。HIV bnAbs 获得大量体细胞突变,但并非所有突变都具有重要的功能。在这项研究中,我们确定了一组足以使天然存在的 V3-聚糖 bnAb DH270.6 发挥功能的最小突变集。通过抗体文库筛选,在体外鉴定和选择与包含这组关键突变的 DH270.6 样抗体相互作用的候选包膜免疫原。我们的研究结果表明,与自然观察到的情况相比,通过疫苗接种诱导 HIV bnAbs 所需的 B 细胞进化途径较不复杂,并且为鉴定增强候选免疫原提供了合理的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41fe/8493474/85048f0d9c73/nihms-1734084-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41fe/8493474/4d24b0d022fe/nihms-1734084-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41fe/8493474/589e97732c4d/nihms-1734084-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41fe/8493474/c3fa573b328a/nihms-1734084-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41fe/8493474/afd2f5e16708/nihms-1734084-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41fe/8493474/c2d55b42a089/nihms-1734084-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41fe/8493474/85048f0d9c73/nihms-1734084-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41fe/8493474/4d24b0d022fe/nihms-1734084-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41fe/8493474/589e97732c4d/nihms-1734084-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41fe/8493474/c3fa573b328a/nihms-1734084-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41fe/8493474/afd2f5e16708/nihms-1734084-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41fe/8493474/c2d55b42a089/nihms-1734084-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41fe/8493474/85048f0d9c73/nihms-1734084-f0007.jpg

相似文献

1
Rapid selection of HIV envelopes that bind to neutralizing antibody B cell lineage members with functional improbable mutations.快速选择与具有功能上不可能突变的中和抗体 B 细胞谱系成员结合的 HIV 包膜。
Cell Rep. 2021 Aug 17;36(7):109561. doi: 10.1016/j.celrep.2021.109561.
2
Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody induction.基于突变的疫苗设计:一种开发 HIV 广谱中和抗体诱导增强免疫原的方法。
Cell Host Microbe. 2024 May 8;32(5):693-709.e7. doi: 10.1016/j.chom.2024.04.006. Epub 2024 Apr 25.
3
Strategies for induction of HIV-1 envelope-reactive broadly neutralizing antibodies.HIV-1 包膜反应性广谱中和抗体的诱导策略。
J Int AIDS Soc. 2021 Nov;24 Suppl 7(Suppl 7):e25831. doi: 10.1002/jia2.25831.
4
Functional Stability of HIV-1 Envelope Trimer Affects Accessibility to Broadly Neutralizing Antibodies at Its Apex.HIV-1包膜三聚体的功能稳定性影响其顶端对广泛中和抗体的可及性。
J Virol. 2017 Nov 30;91(24). doi: 10.1128/JVI.01216-17. Print 2017 Dec 15.
5
Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.多种重组HIV-1包膜蛋白无法激活表达广泛中和抗HIV-1抗体PG9和447-52D的种系B细胞受体的B细胞。
J Virol. 2014 Mar;88(5):2645-57. doi: 10.1128/JVI.03228-13. Epub 2013 Dec 18.
6
Two classes of broadly neutralizing antibodies within a single lineage directed to the high-mannose patch of HIV envelope.同一谱系内两类针对HIV包膜高甘露糖区域的广泛中和抗体。
J Virol. 2015 Jan 15;89(2):1105-18. doi: 10.1128/JVI.02905-14. Epub 2014 Nov 5.
7
Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing Antibodies.HIV 包膜关键残基的正选择可区分广谱和株特异性血浆中和抗体。
J Virol. 2019 Mar 5;93(6). doi: 10.1128/JVI.01685-18. Print 2019 Mar 15.
8
Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies.B细胞谱系在诱导HIV-1广泛中和抗体中的协同作用。
Cell. 2014 Jul 31;158(3):481-91. doi: 10.1016/j.cell.2014.06.022. Epub 2014 Jul 24.
9
A Rare Mutation in an Infant-Derived HIV-1 Envelope Glycoprotein Alters Interprotomer Stability and Susceptibility to Broadly Neutralizing Antibodies Targeting the Trimer Apex.婴儿来源的 HIV-1 包膜糖蛋白中的一个罕见突变改变了二聚体间的稳定性,并影响了针对三聚体顶部的广谱中和抗体的敏感性。
J Virol. 2020 Sep 15;94(19). doi: 10.1128/JVI.00814-20.
10
Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies.HIV-1聚糖依赖性广泛中和抗体的阶段性诱导
Sci Transl Med. 2017 Mar 15;9(381). doi: 10.1126/scitranslmed.aai7514.

引用本文的文献

1
Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodies.工程化免疫原,以选择 HIV 广谱中和抗体中的特定突变。
Nat Commun. 2024 Nov 3;15(1):9503. doi: 10.1038/s41467-024-53120-9.
2
Computing the inducibility of B cell lineages under a context-dependent model of affinity maturation: Applications to sequential vaccine design.在亲和力成熟的上下文相关模型下计算B细胞谱系的诱导性:在序贯疫苗设计中的应用。
bioRxiv. 2023 Oct 17:2023.10.13.562156. doi: 10.1101/2023.10.13.562156.
3
Identification of CDRH3 loops in the B cell receptor repertoire that can be engaged by candidate immunogens.

本文引用的文献

1
HIV-1 VRC01 Germline-Targeting Immunogens Select Distinct Epitope-Specific B Cell Receptors.HIV-1 VRC01 种系靶向免疫原选择不同的表位特异性 B 细胞受体。
Immunity. 2020 Oct 13;53(4):840-851.e6. doi: 10.1016/j.immuni.2020.09.007.
2
VRC34-Antibody Lineage Development Reveals How a Required Rare Mutation Shapes the Maturation of a Broad HIV-Neutralizing Lineage.VRC34 抗体谱系发育揭示了必需的稀有突变如何塑造广谱 HIV 中和谱系的成熟。
Cell Host Microbe. 2020 Apr 8;27(4):531-543.e6. doi: 10.1016/j.chom.2020.01.027. Epub 2020 Mar 3.
3
Restricted Clonality and Limited Germinal Center Reentry Characterize Memory B Cell Reactivation by Boosting.
鉴定 B 细胞受体库中可被候选免疫原结合的 CDRH3 环。
PLoS Pathog. 2023 May 17;19(5):e1011401. doi: 10.1371/journal.ppat.1011401. eCollection 2023 May.
4
Structural basis for breadth development in the HIV-1 V3-glycan targeting DH270 antibody clonal lineage.HIV-1 V3 聚糖靶向 DH270 抗体克隆谱系广度发展的结构基础。
Nat Commun. 2023 May 15;14(1):2782. doi: 10.1038/s41467-023-38108-1.
5
Analysis of two cooperating antibodies unveils immune pressure imposed on HIV Env to elicit a V3-glycan supersite broadly neutralizing antibody lineage.分析两种协同作用的抗体揭示了免疫压力对 HIV Env 的影响,从而诱导产生广泛中和抗体谱系的 V3-聚糖超位点。
Front Immunol. 2022 Sep 26;13:962939. doi: 10.3389/fimmu.2022.962939. eCollection 2022.
6
Complementary Roles of Antibody Heavy and Light Chain Somatic Hypermutation in Conferring Breadth and Potency to the HIV-1-Specific CAP256-VRC26 bNAb Lineage.抗体重链和轻链体细胞超突变在赋予 HIV-1 特异性 CAP256-VRC26 bNAb 谱系广度和效力方面的互补作用。
J Virol. 2022 May 25;96(10):e0027022. doi: 10.1128/jvi.00270-22. Epub 2022 May 5.
7
Neutralization Sensitivity of HIV-1 CRF07_BC From an Untreated Patient With a Focus on Evolution Over Time.HIV-1 CRF07_BC 对未经治疗的患者的中和敏感性,重点关注随时间的演变。
Front Cell Infect Microbiol. 2022 Mar 17;12:862754. doi: 10.3389/fcimb.2022.862754. eCollection 2022.
通过增强作用来激活记忆 B 细胞时表现出受限的克隆性和有限的生发中心再进入。
Cell. 2020 Jan 9;180(1):92-106.e11. doi: 10.1016/j.cell.2019.11.032. Epub 2019 Dec 19.
4
Targeted selection of HIV-specific antibody mutations by engineering B cell maturation.通过工程化 B 细胞成熟来靶向选择 HIV 特异性抗体突变。
Science. 2019 Dec 6;366(6470). doi: 10.1126/science.aay7199.
5
A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses.一种用于诱导广泛中和抗体反应的通用 HIV 疫苗设计策略。
Science. 2019 Dec 6;366(6470). doi: 10.1126/science.aax4380. Epub 2019 Oct 31.
6
Multiple roles for HIV broadly neutralizing antibodies.HIV 广谱中和抗体的多种作用。
Sci Transl Med. 2019 Oct 30;11(516). doi: 10.1126/scitranslmed.aaz2686.
7
Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies.基于中和作用的设计,产生了对 CH235 谱系 CD4bs 广谱中和抗体的未突变共同祖先具有高亲和力的 HIV-1 包膜三聚体。
PLoS Pathog. 2019 Sep 17;15(9):e1008026. doi: 10.1371/journal.ppat.1008026. eCollection 2019 Sep.
8
Coevolution of HIV-1 and broadly neutralizing antibodies.HIV-1 与广谱中和抗体的共同进化。
Curr Opin HIV AIDS. 2019 Jul;14(4):286-293. doi: 10.1097/COH.0000000000000550.
9
Inference of the HIV-1 VRC01 Antibody Lineage Unmutated Common Ancestor Reveals Alternative Pathways to Overcome a Key Glycan Barrier.推断 HIV-1 VRC01 抗体谱系未突变的共同祖先揭示了克服关键聚糖障碍的替代途径。
Immunity. 2018 Dec 18;49(6):1162-1174.e8. doi: 10.1016/j.immuni.2018.10.015. Epub 2018 Dec 11.
10
Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers.HIV-1 感染精英中和抗体者中广谱中和抗体的发展。
Retrovirology. 2018 Sep 5;15(1):61. doi: 10.1186/s12977-018-0443-0.